PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Hematology and Medical Oncology, Icahn School of Medicine, One Gustave L. Levy Place, Box 1079, New York, NY, 10029-6574, USA. hannah.levavi@mountsinai.org.\', \'Division of Hematology and Medical Oncology, Icahn School of Medicine, One Gustave L. Levy Place, Box 1079, New York, NY, 10029-6574, USA.\', \'Tisch Cancer Institute, New York, NY, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s00277-021-04662-1
?:doi
?:hasPublicationType
?:journal
  • Annals of hematology
is ?:pmid of
?:pmid
?:pmid
  • 34549309
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.043
?:rankingScore_hIndex
  • 70
is ?:relation_isRelatedTo_publication of
?:title
  • Impact of rituximab on COVID-19 outcomes.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34549309>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34549309>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all